EWZ vs XBI
iShares MSCI Brazil ETF vs SPDR S&P Biotech ETF
- • XBI has the lower expense ratio at 0.35% vs 0.59% for EWZ.
- • EWZ pays a higher dividend yield (4.16%).
Side-by-side metrics
| Metric | EWZ | XBI |
|---|---|---|
Expense ratio Annual fee. Lower is better. | 0.59% | 0.35% |
Dividend yield Trailing 12-month yield. | 4.16% | 0.34% |
AUM Assets under management — bigger funds are typically more liquid. | $11.57B | $8.30B |
YTD return | 25.59% | 12.92% |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | 1.02 | 1.09 |
P/E ratio | 12.47 | — |
Last price | $38.80 | $133.66 |
Inception | — | — |
Issuer | iShares | State Street |
EWZ top holdings
| VALE3.SA | Vale SA | 10.39% |
| NU | Nu Holdings Ltd Ordinary Shares Class A | 8.74% |
| ITUB4 | Itau Unibanco Holding SA Participating Preferred | 8.43% |
| PETR4 | Petroleo Brasileiro SA Petrobras Participating Preferred | 7.84% |
| PETR3.SA | Petroleo Brasileiro SA Petrobras | 7.23% |
| B3SA3.SA | B3 SA - Brasil Bolsa Balcao | 3.60% |
| BBDC4 | Bank Bradesco SA Participating Preferred | 3.35% |
| SBSP3.SA | Companhia De Saneamento Basico Do Estado De Sao Paulo | 3.12% |
| AXIA3.SA | Axia Energia | 2.87% |
| WEGE3.SA | Weg SA | 2.85% |
XBI top holdings
| APLS | Apellis Pharmaceuticals Inc | 1.87% |
| RVMD | Revolution Medicines Inc Ordinary Shares | 1.65% |
| TVTX | Travere Therapeutics Inc Ordinary Shares | 1.62% |
| ARWR | Arrowhead Pharmaceuticals Inc | 1.44% |
| TWST | Twist Bioscience Corp | 1.42% |
| SMMT | Summit Therapeutics Inc Ordinary Shares | 1.40% |
| ALKS | Alkermes PLC | 1.38% |
| TGTX | TG Therapeutics Inc | 1.37% |
| MDGL | Madrigal Pharmaceuticals Inc | 1.36% |
| BEAM | Beam Therapeutics Inc | 1.32% |
About EWZ
EWZ (iShares MSCI Brazil ETF) is Brazilian large- and mid-cap equities. Managed by iShares, the fund carries $11.6B in assets under management, an expense ratio of 0.59%, a dividend yield of 4.16%. Its largest holding is Vale SA (VALE3.SA), which represents 10.4% of the portfolio. Consumer Cyclical is the fund's largest sector exposure at 1.5%.
About XBI
XBI (SPDR S&P Biotech ETF) is Equal-weight biotech stocks in the S&P Biotech Index. Managed by State Street, the fund carries $8.3B in assets under management, an expense ratio of 0.35%, a dividend yield of 0.34%. Its largest holding is Apellis Pharmaceuticals Inc (APLS), which represents 1.9% of the portfolio. Financial Services is the fund's largest sector exposure at 0.2%.